1
|
Ferriani LO, Silva DA, Molina MDCB, Mill JG, Brunoni AR, da Fonseca MDJM, Moreno AB, Benseñor IM, de Aguiar OB, Barreto SM, Viana MC. Depression is a risk factor for metabolic syndrome: Results from the ELSA-Brasil cohort study. J Psychiatr Res 2023; 158:56-62. [PMID: 36571912 DOI: 10.1016/j.jpsychires.2022.12.017] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Revised: 12/12/2022] [Accepted: 12/19/2022] [Indexed: 12/24/2022]
Abstract
INTRODUCTION Metabolic Syndrome (MetS) and depression comorbidity has been recognized, but its directionality is still uncertain. The aims of this study was to assess the association between depression (diagnosis and severity) and MetS (components, diagnosis and trajectory) in the baseline and over a 4-year follow-up period. MATERIAL AND METHODS Baseline and follow-up data from 13,883 participants of the Brazilian Longitudinal Study of Adult Health were analyzed. The Clinical Interview Schedule Revised assessed depressive episode and its severity. MetS components and diagnosis were assessed according to the National Cholesterol Education Program Adult Treatment Panel III. Participants were grouped according to MetS trajectory as recovered, incident and persistent MetS. Logistic regression analysis was conducted estimating odds ratios (OR) and 95% confidence intervals (95%CI). RESULTS Baseline depression was positively associated with recovered (OR = 1.59, 95%CI 1.18-2.14), incident (OR = 1.45, 95%CI 1.09-1.91) and persistent (OR = 1.70, 95%CI 1.39-2.07) MetS. Baseline depression was also associated with large waist circumference (OR = 1.47, 95%CI 1.23-1.75), high triglycerides (OR = 1.23, 95%CI 1.02-1.49), low high-density lipoprotein cholesterol (OR = 1.30, 95%CI 1.08-1.56), and hyperglycemia (OR = 1.38, 95%CI 1.15-1.66) at follow-up. Having three or more MetS components at follow-up was associated with baseline depression, with a positive dose-response effect (OR = 1.77, 95%CI 1.29-2.43; OR = 1.79, 95%CI 1.26-2.54; OR = 2.27, 95%CI 1.50-3.46, respectively). The magnitude of associations was greater in severe depression, when compared to moderate and mild. DISCUSSION These results support that depression is a risk factor for the development of MetS and highlights the need to follow metabolic and cardiovascular alterations in the presence of depression.
Collapse
Affiliation(s)
- Lara Onofre Ferriani
- Postgraduate Program in Public Health, Federal University of Espírito Santo, Vitória, ES, Brazil.
| | - Daniela Alves Silva
- Department of Health Integrated Education, Federal University of Espírito Santo, Vitória, ES, Brazil
| | - Maria Del Carmen Bisi Molina
- Postgraduate Program in Public Health, Federal University of Espírito Santo, Vitória, ES, Brazil; Postgraduate Program in Health and Nutrition, Federal University of Ouro Preto, Ouro Preto, MG, Brazil
| | - José Geraldo Mill
- Postgraduate Program in Public Health, Federal University of Espírito Santo, Vitória, ES, Brazil; Department of Physiological Sciences, Federal University of Espírito Santo, Vitória, ES, Brazil
| | - André Russowsky Brunoni
- Center for Clinical and Epidemiological Research, University of São Paulo, São Paulo, SP, Brazil
| | - Maria de Jesus Mendes da Fonseca
- Department of Epidemiology and Quantitative Methods in Health, Nacional School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil
| | - Arlinda B Moreno
- Department of Epidemiology and Quantitative Methods in Health, Nacional School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil
| | - Isabela M Benseñor
- Center for Clinical and Epidemiological Research, University of São Paulo, São Paulo, SP, Brazil
| | | | - Sandhi Maria Barreto
- Medical School & Clinical Hospital, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
| | - Maria Carmen Viana
- Postgraduate Program in Public Health, Federal University of Espírito Santo, Vitória, ES, Brazil; Departament of Social Medicine, Federal University of Espírito Santo, Vitória, ES, Brazil
| |
Collapse
|